2-mercaptoethylguanidine has been researched along with Anemia, Sickle Cell in 2 studies
2-mercaptoethylguanidine: proposed as a radiation protective agent; minor descriptor (75-83); on-line & Index Medicus search GUANIDINES (75-83); RN given refers to parent cpd
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiroycheva, M | 2 |
| Ahmed, F | 1 |
| Anthony, GM | 2 |
| Szabo, C | 2 |
| Southan, GJ | 2 |
| Bank, N | 2 |
| Singhal, PC | 1 |
2 other studies available for 2-mercaptoethylguanidine and Anemia, Sickle Cell
| Article | Year |
|---|---|
Mitogen-activated protein kinase phosphorylation in kidneys of beta(s) sickle cell mice.
Topics: Analysis of Variance; Anemia, Sickle Cell; Animals; Blotting, Western; Enzyme Inhibitors; Guanidines | 2000 |
Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys.
Topics: Alanine Transaminase; Anemia, Sickle Cell; Animals; Apoptosis; Aspartate Aminotransferases; Blotting | 2000 |